<DOC>
	<DOCNO>NCT01050816</DOCNO>
	<brief_summary>An open clinical trial transplant CHONDRON ( autologous chondrocytes ) ankle cartilage defect patient appropriate trial , evaluate validity safety 12 month .</brief_summary>
	<brief_title>Effects CHONDRON ( Autologous Chondrocytes ) With Ankle Cartilage Defect</brief_title>
	<detailed_description>This clinical trial design observe effect CHONDRON ( autologous chondrocytes ) 12 month patient ankle cartilage defect . In clinical trial , 30 subject screened- 4 exclude half way 26 finish trial . Full-thickness articular cartilage specimen obtain site direct articulation within ankle joint ( anterior talus , anterior process calcaneus , calcaneocuboid joint area . ) Gel-type CHONDRON ( Fibrin mixed Autologous chondrocytes ) transplant defect . Evaluation variable AOFAS , 100 mm VAS , HANNOVER score , self-assessment improvement patient , MRI arthroscopy .</detailed_description>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>1. adult men woman 15 less 65 year age 2. applied patient arthroscopically grossly confirm , partial cartilage defect ankle joint 3. patient ankletibia malalignment ankle joint , unstable ankle ligament , bone defect cartilage defect area patient receive correction advance . 4. patient surround cartilage normal 5. patient agree clinical trial participation voluntarily person parental authority , sign write consent form 1. patient hypersensitive bovine protein 2. patient hypersensitive gentamicin antibiotic 3. patient inflammatory arthritis rheumatoid arthritis , gout arthritis 4. patient arthritis relate autoimmune disease 5. pregnant , breastfeed patient possibility pregnancy 6. patient accompany disease articular cartilage defect , include tumor 7. patient history receive radiotherapy , chemotherapy last 2 year 8. patient diabetes ( however , patient whose blood sugar test result normal complication diabetes , write opinion CHONDRON administration possible append doctor exclude ) 9. patient administer antibiotic antimicrobial agent due infection 10. patient receive steroid hormone therapy 11 . Patients psychiatric disorder consider inappropriate trial judgment clinical trial manager</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>articular cartilage defect</keyword>
	<keyword>ACI</keyword>
	<keyword>ankle joint</keyword>
	<keyword>chondron</keyword>
</DOC>